Press Release

Immunodiagnostics Market Global Share, Growth, Size, Opportunities, Trends, Regional Overview, Leading Company Analysis, And Key Country Forecast To 2025

Immunodiagnostics Market | Global Industry Size, In-Depth Qualitative Insights, Explosive Growth Opportunity, Regional Analysis by Fortune Business Insights

The increasing number of geriatric population, and occurrences of infectious diseases like cancer, and hepatitis is expected to boost the global immunodiagnostics market. According to a report published by Fortune Business Insights, titled “Immunodiagnostics: Global Market Analysis, Insights, and Forecast, 2018-2025,” the market was valued at US$ 15,777.5 Mn in 2017. Fortune Business Insights predicts that the market will rise at a CAGR of 4.7%, and reach US$ 22,732.7 Mn by the end of 2025.

For more information in the analysis of this report, visit:

Oncology and Endocrinology Segment Will Witness Increasing Demand

The immunodiagnostic market is categorized into oncology and endocrinology, infectious disease testing, hepatitis and retrovirus testing, and GI stool testing in terms of application. In 2017, oncology, and endocrinology segment had generated a market share of 25.6%. The segment’s highest share is accredited to the embracing of immunodiagnostics in various applications, namely endocrine diseases and cancer. There has been an increase in the number of reimbursement of products as well as new product approvals. Also, several tests are predicted to propel the global immunodiagnostics market by the end of 2025.

Request a Sample Copy of the Global Immunodiagnostics Market Research Report:

Key Industry Developments

  • In March 2019, Oncimmune announced the acquisition of Protagen Diagnostics.
  • In November 2018, Ortho Clinical Diagnostics received U.S FDA approval for the company’s VITROS HIV Combo test, an immunodiagnostic detect HIV-1 and HIV-2 antibodies (Ab) and the p24 antigen (Ag).
  • In May 2016, Diasorin announced the acquisition of Quest Diagnostics’ immunodiagnostics products.

Some of the leading companies that are operating in the global immunodiagnostics market are

  • Abbott,
  • Hoffmann-La Roche AG (Roche Diagnostics),
  • DiaSorin,
  • Danaher Corporation,
  • bioMérieux,
  • Thermo Fisher Scientific,
  • Quest Diagnostics.


By Product

  • Instruments
  • Reagents & Consumables

By Application

  • Oncology & Endocrinology
  • Hepatitis & Retrovirus
  • Cardiac Markers
  • Infectious Diseases
  • Others

By End user

  • Clinical Laboratories
  • Hospitals
  • Physician’s Offices
  • Others

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

More Trending Topics From Fortune Business [email protected]

Automated Suturing Devices Market Share In-Depth Analysis of Industry Growth Trends & Forecast up to 2026

Chronic Wound Care Market 2019: Global Industry Overview By Share, Trends, Opportunities, Historical Analysis, and Industry Segments Poised for Rapid Growth by 2026

Cosmetic Dentistry Market Global Industry Growth, Historical Analysis, Size, Trends, Emerging Factors, Demands, Key Players, Emerging Technologies and Potential of Industry Till 2026

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *